Sebastian Wanless
Corporate Officer/Principal presso TCB Newco Ltd.
Posizioni attive di Sebastian Wanless
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - | - |
Storia della carriera di Sebastian Wanless
Precedenti posizioni note di Sebastian Wanless
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Corporate Officer/Principal | 01/09/2020 | 01/09/2022 |
| Bristol-Myers Squibb Foundation | Corporate Officer/Principal | 01/01/2003 | 01/01/2007 |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Stati Uniti | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Aziende private | 2 |
|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
| Bristol-Myers Squibb Foundation |
- Borsa valori
- Insiders
- Sebastian Wanless
- Esperienza
